Navigation Links
Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
Date:4/26/2012

eater than or equal to 10 percent of Vimpat® -treated patients, and greater than placebo, were dizziness, headache, nausea and diplopia.  Additional important safety information for Vimpat® is available at the end of the press release.

In the European Union, Vimpat® (film-coated tablets and solution for infusion) is approved as adjunctive therapy for the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy, aged 16 years and older.  Vimpat® solution for infusion may be used when oral administration is temporarily not feasible.

The maximum recommended daily dose for Vimpat® in the European Union and the U.S. is 400 mg/day.

Important safety information about Vimpat® in the U.S.

Warnings and Precautions
AEDs increase the risk of suicidal behavior and ideation. Patients taking Vimpat® should be monitored for the emergence or worsening of depression, suicidal thoughts or behavior, and/or any unusual changes in mood or behavior.

Patients should be advised that Vimpat® may cause dizziness, ataxia, and syncope. Caution is advised for patients with known cardiac conduction problems, who are taking drugs known to induce PR interval prolongation, or with severe cardiac disease. In patients with seizure disorders, Vimpat® should be gradually withdrawn to minimize the potential of increased seizure frequency. Multi-organ hypersensitivity reactions have been reported with antiepileptic drugs. If this reaction is suspected, treatment with Vimpat® should be discontinued.

Vimpat® oral solution contains aspartame, a source of phenylalanine. A 200 mg dose of Vimpat® oral solution (equivalent to 20 mL) contains 0.32 mg of phenylalanine.

Common Adverse Reactions
The most common adverse reactions occurring in greater than or equal to 10 percent of Vimpat®-t
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
3. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
4. Interim Safety Data Favorable for Vicals Phase 2 Trial of DNA Vaccine Against CMV
5. Interim Phase 2 Data for Exelixis XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer
6. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
7. Grantees of the Avon Foundation Breast Cancer Prevention Research Initiative Gather in Houston to Report Interim Findings
8. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
9. Interim Safety Analysis Supports Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma
10. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
11. NanoBio Corporation Presents Preclinical and Interim Clinical Data on Topical Treatments for Herpes Labialis and Onychomycosis at AAD 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 25, 2015 Research and Markets ... of the "Research and Future Development Trend Forecast ... offering. At present, there are 35,600 dialysis ... concentration ratio are large due to the different regional ... dialysis centers in other Asian countries are operated by ...
(Date:5/27/2015)... 2015  Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... pain, announced today that it will present at the ... 2015 at the Luxe Sunset Hotel in ... presentation by Michael Becker , Relmada,s senior vice ... begin at 2:00 p.m. PT/5:00 p.m. ET. A live ...
(Date:5/27/2015)... , May 27, 2015  Halozyme Therapeutics, Inc. ... (Ventana), a member of the Roche Group, announced today ... and for Ventana to ultimately commercialize, a companion diagnostic ... The Ventana assay will be used ... a glycosaminoglycan – a chain of natural sugars distributed throughout ...
Breaking Medicine Technology:China Dialysis Market Report: Research and Future Development Trends and Forecasts 2015-2020 2Relmada Therapeutics to Present at the 2015 LD Micro Invitational Conference 2Relmada Therapeutics to Present at the 2015 LD Micro Invitational Conference 3Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment 2Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment 3Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment 4Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment 5
... SAN DIEGO , Jan. 20, 2010 Amylin Pharmaceuticals, ... for the fourth quarter and full year 2009 on Wednesday, January ... . Daniel M. Bradbury , Amylin,s president and chief executive officer, ... financial results for the fourth quarter and year ended December 31, ...
... 20 Roper Industries, Inc.   (NYSE: ... of 2009, ended December 31, 2009 , will be released before ... call to discuss these results has been scheduled for 8:30 AM ... be accessed via webcast or by dialing +1 888-539-3679 (US/ Canada ) ...
Cached Medicine Technology:Amylin Pharmaceuticals to Webcast Year-End Financial Results 2
(Date:5/27/2015)... MD (PRWEB) May 27, 2015 Representatives ... attend this year’s conference of the American Immigration Lawyers ... the Gaylord National Resort. MCA’s booth is #404. , ... Gathering in Immigration Law.” MCAads.com, a regular AILA conference ... meeting” as they welcome current clients to their booth ...
(Date:5/27/2015)... The Society for Women's Health Research ... research on sex differences in health and disease, today ... advocates, organizations, and celebrities in bringing awareness to the ... campaign features a short film that shares the stories ... as a result of their abuse, as well as ...
(Date:5/27/2015)... FL (PRWEB) May 27, 2015 A. ... plastic surgeon announces the addition of UltraShape® , ... Syneron Candela, to his Tampa Plastic Surgery Center. ... destruction, UltraShape is the first and only non-invasive body ... precisely target subcutaneous fat, without harming the surrounding tissue, ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 The Case ... its highest honor, the CMSA Lifetime Achievement Award, to ... ceremony on Thursday, June 25th at the association’s 25th ... in Orlando, Florida. , The CMSA Board of Directors ... who has made a significant contribution to practice of ...
(Date:5/27/2015)... May 27, 2015 SIMpalm , ... its client to launch an Android version for Forte ... to accept credit, debit and ACH payments on Android ... Play at: https://play.google.com/store/apps/details?id=com.simpalm.paymentgateway . The iOS version of ... been recently updated by SIMpalm. , Forte Mobile ...
Breaking Medicine News(10 mins):Health News:PERM Specialists from MCAads.com Will Attend the 2015 Conference on Immigration Law Set for June 17-20 in the DC Metro Area 2Health News:PERM Specialists from MCAads.com Will Attend the 2015 Conference on Immigration Law Set for June 17-20 in the DC Metro Area 3Health News:The Society for Women’s Health Research Announces “Beyond the Bruises” Campaign Highlighting the Effects of Domestic Violence on Chronic Disease 2Health News:The Society for Women’s Health Research Announces “Beyond the Bruises” Campaign Highlighting the Effects of Domestic Violence on Chronic Disease 3Health News:Tampa Plastic Surgery Center Delivers A Better Way To A Better Body 2Health News:Tampa Plastic Surgery Center Delivers A Better Way To A Better Body 3Health News:CMSA to Present Prestigious Lifetime Achievement Award to Anne Llewellyn RN-BC, MS, BHSA, CCM, CRRN 2Health News:Forte Payment System Launches Android Version of Payment App 2
... ... Company to Hold Conference Call on April 24 at 8:00 a.m. ET - ... Reaffirmed Full ... SMA ), a leading independent provider of products to the global,orthopedic device industry and ...
... Aflac,Incorporated today reported its first quarter results., ... revenues were $4.3 billion during the first quarter ... quarter of 2007. Net earnings were,$474 million, or ... or,$.84 per share, a year ago. Net earnings ...
... (NYSE: BSX ) today announced that it ... in the GHXcellence Awards for achievements,in improving supply ... of electronic transactions to improve supply,chain efficiency for ... granted by GHX based on application of the,following ...
... Heeding the voice of the,public, Hero Nutritionals, Inc. ... vitamins for adults. Hero Nutritionals, manufacturer of Yummi,Bears, the ... demand from moms buying Yummi Bears, for an adult ... the category. Yummi Bears is the,nation,s #1 & best ...
... pass,companion bill and send measure to President, BALTIMORE, ... the Protecting the Medicaid Safety Net Act of,2008, which ... bill,prevents massive increases in costs for people in Medicaid ... vote is a victory for all Marylanders who rely ...
... to treat eye disease, study finds , , ... moderate levels of the eye disease trachoma, one or ... antibiotic azithromycin may be sufficient to eliminate the infection, ... London School of Hygiene & Tropical Medicine,s Trachoma Group ...
Cached Medicine News:Health News:Symmetry Medical Reports Full Year 2007 Financial Results 2Health News:Symmetry Medical Reports Full Year 2007 Financial Results 3Health News:Symmetry Medical Reports Full Year 2007 Financial Results 4Health News:Symmetry Medical Reports Full Year 2007 Financial Results 5Health News:Symmetry Medical Reports Full Year 2007 Financial Results 6Health News:Symmetry Medical Reports Full Year 2007 Financial Results 7Health News:Symmetry Medical Reports Full Year 2007 Financial Results 8Health News:Symmetry Medical Reports Full Year 2007 Financial Results 9Health News:Aflac Incorporated Announces First Quarter Results, Declares Second Quarter Cash Dividend 2Health News:Aflac Incorporated Announces First Quarter Results, Declares Second Quarter Cash Dividend 3Health News:Aflac Incorporated Announces First Quarter Results, Declares Second Quarter Cash Dividend 4Health News:Aflac Incorporated Announces First Quarter Results, Declares Second Quarter Cash Dividend 5Health News:Aflac Incorporated Announces First Quarter Results, Declares Second Quarter Cash Dividend 6Health News:Aflac Incorporated Announces First Quarter Results, Declares Second Quarter Cash Dividend 7Health News:Aflac Incorporated Announces First Quarter Results, Declares Second Quarter Cash Dividend 8Health News:Aflac Incorporated Announces First Quarter Results, Declares Second Quarter Cash Dividend 9Health News:Aflac Incorporated Announces First Quarter Results, Declares Second Quarter Cash Dividend 10Health News:Boston Scientific Named Healthcare Supplier of the Year by Global Healthcare Exchange (GHX) 2Health News:Boston Scientific Named Healthcare Supplier of the Year by Global Healthcare Exchange (GHX) 3Health News:Boston Scientific Named Healthcare Supplier of the Year by Global Healthcare Exchange (GHX) 4Health News:Hero Nutritionals Introduces a New Adult Vitamin for the Taste Buds 2Health News:AARP Thanks Maryland's Representatives for Supporting Bill to Protect People in Medicaid 2Health News:Annual Trachoma Treatments May Be Unnecessary 2
The SJM Sguin annuloplasty ring, a semi-rigid ring, is constructed of a one-piece solid core of ultra-high-weight polyethylene enclosed in a knitted polyester sewing cuff....
Diagnostic and laboratory test reference. Get help with test preparation, interpretation, follow-up, and reimbursement....
... HIPAA-compliant wireless technology that makes fully ... and personnel a reality. This advance ... or levels means a ... shorter hospital stays and improved outcomes. ...
... Focus from Thermo Labsystems was designed specifically ... Advanced features such as the new fast ... on microvolumes help to define this as ... The new interchangeable handle plate offers a ...
Medicine Products: